European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

Results from the Phase III PREVAIL trial (NCT05556096) of gefurulimab demonstrated a statistically significant and clinically ...

In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.

MRK is gearing up to report Q2 earnings. While Keytruda drives growth, there are concerns over Gardasil's China sales, generics and pipeline depth.

Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

Colorcon, Inc. (Harleysville, Pa.), a manufacturer of of film coating systems, specialty excipients, controlled release ...

Another FTSE 100-listed (^FTSE) giant reporting in the week ahead is pharmaceuticals company AstraZeneca (AZN.L), which has ...

With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...

President Donald Trump said he is considering rebates to US taxpayers from billions in tariff revenue flowing into the ...

A Venezuelan baseball team was denied visas into the United States and will miss this year's Senior Baseball World Series, Little League International confirmed Friday.

The District of Columbia Council is set to vote Aug. 1 on revised legislation that could allow the Washington Commanders to ...

Aetna clients in Virginia and other states will no longer be able to purchase individual or family health insurance plans ...